Evonik opens its largest center for medical device applications in Shanghai, China, which aims to serve the entire Asian market.

This cutting-edge facility specializes in the research, development, and processing of semi-finished components for bioresorbable medical devices, aiming to support customers in overcoming challenges related to the innovation of high-quality medical devices.

The new Evonik Shanghai Medical Device Center.

“Our next-generation biomaterials are enabling our customers to innovate new medical technologies that create life beyond limits. The latest addition to our global technical service network can help more customers across Asia in reducing complexity, accelerating time to market, and improving medical device performance,” says Yann d’Hervé, head of Evonik Health Care.

Opening ceremony of the new medical device center.

The Evonik Shanghai Medical Device Center offers comprehensive one-stop solutions that range from concept development, material selection and customization, prototyping and processing, analytical services, quality and regulatory documentation, to manufacturing semi-finished products and components in an ISO class 7 cleanroom environment.

By utilizing advanced processing technologies, the center converts Evonik’s wide range of standard and customized biomaterials into various types of semi-finished components. These components are designed with specific properties, including bioresorbability, low-friction, antithrombotic and antibacterial characteristics.

Medical device manufacturers can then further process them to meet specific requirements for diverse applications in orthopedics, sports medicine, general surgery, cardiovascular care, neurosurgery, urology, aesthetics, ophthalmology, and dental care.

“The innovation of high-end medical devices plays a key role in the government’s Healthy China 2030 initiative. Manufacturers are increasingly pursuing competitive raw materials and service solutions to differentiate themselves in the world’s second-largest medical device market,” said Fuliang Xia, President of Evonik Greater China. “Our new center is strategically aligned with these urgent market demands and contributes to the acceleration of industrial upgrading.”

Evonik opens its largest center for medical device applications in Shanghai, China, which aims to serve the entire Asian market.

This cutting-edge facility specializes in the research, development, and processing of semi-finished components for bioresorbable medical devices, aiming to support customers in overcoming challenges related to the innovation of high-quality medical devices.

The new Evonik Shanghai Medical Device Center.

“Our next-generation biomaterials are enabling our customers to innovate new medical technologies that create life beyond limits. The latest addition to our global technical service network can help more customers across Asia in reducing complexity, accelerating time to market, and improving medical device performance,” says Yann d’Hervé, head of Evonik Health Care.

Opening ceremony of the new medical device center.

The Evonik Shanghai Medical Device Center offers comprehensive one-stop solutions that range from concept development, material selection and customization, prototyping and processing, analytical services, quality and regulatory documentation, to manufacturing semi-finished products and components in an ISO class 7 cleanroom environment.

By utilizing advanced processing technologies, the center converts Evonik’s wide range of standard and customized biomaterials into various types of semi-finished components. These components are designed with specific properties, including bioresorbability, low-friction, antithrombotic and antibacterial characteristics.

Medical device manufacturers can then further process them to meet specific requirements for diverse applications in orthopedics, sports medicine, general surgery, cardiovascular care, neurosurgery, urology, aesthetics, ophthalmology, and dental care.

“The innovation of high-end medical devices plays a key role in the government’s Healthy China 2030 initiative. Manufacturers are increasingly pursuing competitive raw materials and service solutions to differentiate themselves in the world’s second-largest medical device market,” said Fuliang Xia, President of Evonik Greater China. “Our new center is strategically aligned with these urgent market demands and contributes to the acceleration of industrial upgrading.”